Alloy Therapeutics is a Product Development Organization supporting its partners in the discovery, development, and commercialization of their therapeutic drug programs. Alloy provides AI-powered biotechnology infrastructure through proprietary technology platforms, integrated services, and company creation. Its capabilities span antibodies and multispecifics, genetic medicines, cell therapies, and drug delivery and targeting. As a PDO, Alloy will never develop its own drug pipeline, ensuring full alignment with its partners’ success. Founded in 2017, Alloy has licensed more than 115 therapeutic programs, including 25 in the clinic. Alloy is headquartered in the United States, with operations in Europe, Japan, and the Middle East.
Alloy Therapeutics
Alloy Therapeutics is a Product Development Organization supporting partners in the discovery, development, and commercialization of therapeutic drug programs. Alloy provides AI-powered biotechnology infrastructure through proprietary technology platforms, integrated services, and company creation—with no competing internal drug pipeline.
The Latest Insights & Innovations from
Alloy Therapeutics
Webinar
Beyond Affinity: Multi-Parameter Optimization of Multispecific Building Blocks
October 28, 2026
Learn more
No items found.
No items found.
No items found.